Viewing Study NCT03876093


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-03-02 @ 4:01 PM
Study NCT ID: NCT03876093
Status: WITHDRAWN
Last Update Posted: 2021-04-27
First Post: 2019-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Epilepsy-related Brain Tumors Register
Sponsor: Fondation Hôpital Saint-Joseph
Organization:

Study Overview

Official Title: Epilepsy-related Brain Tumors Register
Status: WITHDRAWN
Status Verified Date: 2021-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: The PI decided.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Epilepsy is defined by a cerebral disorder characterized by a lasting predisposition to generate epileptic seizures and by the neurobiological, cognitive, psychological and social consequences of this affection. The definition of epilepsy requires the occurrence of at least one epileptic seizure. 1% of the population suffers from epilepsy. The most common causes are genetic and vascular, 10% of epileptic syndromes are caused by a tumor.

The incidence of brain tumors in people with epilepsy is approximately 4%. Among patients with brain tumor (s), the frequency of epilepsy is 30% or more depending on type of tumeur. 30-50% of brain tumors are revealed by an epileptic seizure and 10 to 30% of patients with brain tumor (s) will develop seizures during their evolution.

The main objective is to evaluate the frequency of epileptic seizures according to the type of brain tumor.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: